Sirolimus for the Treatment of Hyperinsulinism

NCT02524639 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Due to strict inclusion and exclusion criteria no subjects were enrolled

Conditions

Hyperinsulinism

Interventions

DRUG: Sirolimus

Sponsor

Children's Hospital of Philadelphia